2018 Annual Meeting | C85 - Therapy in Neurology IV: Autoimmune PNS Synaptic Disorders and Neuro-Oncology

Date Monday 04/23/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Madhu Soni, MD, FAAN

Topic(s) General Neurology, Neuro-oncology

Learning Objectives Participants should be able to discuss current treatments and evidence-based guidelines for commonly encountered autoimmune synaptic disorders affecting the peripheral nervous system, and common neuro-oncology disorders.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
03:30 PM - 03:35 PM	Introduction	Madhu Soni, MD, FAAN
03:35 PM - 04:20 PM	Speaker	Therapy of Antibody-mediated Neuromuscular Disorders Steven Vernino, MD, PhD, FAAN
04:20 PM - 04:30 PM	Q&A	Questions and Answers
04:30 PM - 05:15 PM	Speaker	Therapy of Primary and Metastatic Brain Tumors Amy A. Pruitt, MD, FAAN
05:15 PM - 05:30 PM	Q&A	Questions and Answers

Faculty Disclosures
Madhu Soni, MD, FAAN	Dr. Soni has received personal compensation in the range of $500-$4,999 for serving as a Physician Lead (Honorarium) in Women Leading in Neurology Program with American Academy of Neurology.
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Amy A. Pruitt, MD, FAAN	Dr. Pruitt has nothing to disclose.